Results 41 to 50 of about 3,787 (192)
Modern potentials of prokinetics in treatment of gastroesophageal reflux disease
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2010 The aim of review. To estimate up-to-date options and prospects of application of prokinetics in treatment of gastroesophageal reflux disease (GERD).Original positions.
A. A. Sheptulin, V. A. Kiprianis
doaj
Nutrition in Clinical Practice, EarlyView.Abstract Background This study aimed to develop and assess a bedside nasojejunal tube placement technique designed for resource‐limited settings to address the specific challenges of enteral nutrition (EN) delivery in neurocritical care patients, particularly those at high risk of reflux and aspiration. The technique sought to overcome the drawbacks of
Niuchenglin +5 more
wiley +1 more source
Медицинский совет, 2017 Functional gastrointestinal disorders are currently being considered as the most common pathology of the gastrointestinal tract. Symptoms that may be related to the gastroduodenal region, represent one of the major subgroups among functional ...
D. I. Trukhan
doaj +1 more source
Systematic Review and Meta‐Analysis: Plant‐Based Therapy for Irritable Bowel Syndrome
Phytotherapy Research, EarlyView.ABSTRACT Irritable bowel syndrome (IBS) is a common disorder of brain‐gut interaction that presents with abdominal pain, bloating associated with variable stool consistency. Many IBS patients prefer plant‐based preparations to pharmacological therapy; however, the utility of this approach is not well established.
Anselm Meyer +8 more
wiley +1 more source
Small intestinal bacterial overgrowth in patients with systemic sclerosis
Indian Journal of Rheumatology, 2017 Small intestinal bacterial overgrowth (SIBO) is common in patients with systemic sclerosis (SSc) yet often goes underrecognized in clinical practice. In patients with SSc, untreated SIBO may result in marked morbidity and possible mortality.
Saara Rawn +4 more
doaj
Therapeutic role of prokinetic drugs in the treatment of gastroesophageal reflux disease
Медицинский совет, 2014 It is not for nothing that gastroesophageal reflux disease (GERD) is called the "disease of the XXI century": it is characterized by very high incidence and affects people of different age groups.
I. V. Mayev +5 more
doaj +1 more source
Roux‐en‐Y Reconstruction After Esophagectomy for Postoperative Functional Complaints: A Case Series
ANZ Journal of Surgery, EarlyView.Functional complaints affect half of esophagectomy patients, with no standard treatment. In nine patients, Roux‐en‐Y reconstruction for obstruction, redundant conduit, and weight loss was safely performed, with one major complication and no Grade 4 out of five events. Complete symptom resolution reached 67% at 3 months and 89% at 1 year.
Donika Zogaj +6 more
wiley +1 more source
Diabetes, Obesity and Metabolism, EarlyView.ABSTRACT Background Individuals living with type 1 diabetes (T1D) are at increased risk for cardiovascular (CV) and renal complications, yet therapeutic strategies specifically targeting cardiorenal risk reduction in this population remain limited. The role of glucagon‐like peptide‐1 (GLP‐1)‐based therapies in T1D remains unclear.
Anastasios Tentolouris +5 more
wiley +1 more source
The Korean Journal of Gastroenterology, 2019 Dyspepsia is a common problem, and when dyspeptic symptoms develop within a short period of time, organic diseases such as gastroesophageal reflux disease, peptic ulcer diseases, pancreatoduodenal diseases, and gastrointestinal cancers should be ...
Jung Hwan Oh, Joong Goo Kwon
doaj +1 more source
Journal of Evidence-Based Medicine, EarlyView.ABSTRACT Older patients receiving end‐of‐life palliative care often present with multiple geriatric syndromes, frailty, and comorbid symptom burden, resulting in a high risk of medication‐related harm. This guideline focuses on pharmacological management of distressing symptoms in older patients receiving end‐of‐life or hospice‐oriented palliative care,
Daiping Li +7 more
wiley +1 more source